These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19646655)

  • 1. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands as potential therapeutic agents to treat arthritis.
    Giaginis C; Giagini A; Theocharis S
    Pharmacol Res; 2009 Sep; 60(3):160-9. PubMed ID: 19646655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
    Abdelrahman M; Sivarajah A; Thiemermann C
    Cardiovasc Res; 2005 Mar; 65(4):772-81. PubMed ID: 15721857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PPARgamma as a new therapeutic target in inflammatory diseases].
    Naito Y; Yoshikawa T
    Nihon Rinsho; 2010 Feb; 68(2):341-9. PubMed ID: 20158107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis.
    Giaginis C; Margeli A; Theocharis S
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1561-72. PubMed ID: 17922621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma in osteoarthritis.
    Fahmi H; Martel-Pelletier J; Pelletier JP; Kapoor M
    Mod Rheumatol; 2011 Feb; 21(1):1-9. PubMed ID: 20820843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peroxisome proliferator-activated receptors-gamma (PPAR-gamma) and their role in immunoregulation and inflammation control].
    Sokołowska M; Kowalski ML; Pawliczak R
    Postepy Hig Med Dosw (Online); 2005; 59():472-84. PubMed ID: 16258412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) ligands and angiogenesis.
    Margeli A; Kouraklis G; Theocharis S
    Angiogenesis; 2003; 6(3):165-9. PubMed ID: 15041792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
    Han S; Roman J
    Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury.
    Giaginis C; Tsourouflis G; Theocharis S
    Curr Mol Med; 2008 Sep; 8(6):562-79. PubMed ID: 18781963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
    Koufany M; Jouzeau JY; Moulin D
    Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease.
    Atug O; Tahan V; Eren F; Tiftikci A; Imeryuz N; Hamzaoglu HO; Tozun N
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):433-7. PubMed ID: 19104705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis.
    Ivanova EA; Myasoedova VA; Melnichenko AA; Orekhov AN
    Curr Pharm Des; 2017; 23(7):1119-1124. PubMed ID: 27855608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story.
    François M; Richette P; Corvol MT
    Drug News Perspect; 2005 May; 18(4):257-61. PubMed ID: 16034482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma ligands as bone turnover modulators.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Expert Opin Investig Drugs; 2007 Feb; 16(2):195-207. PubMed ID: 17243939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?
    Feinstein DL; Spagnolo A; Akar C; Weinberg G; Murphy P; Gavrilyuk V; Dello Russo C
    Biochem Pharmacol; 2005 Jul; 70(2):177-88. PubMed ID: 15925327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG; Hele DJ; Birrell MA
    Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
    Lea S; Plumb J; Metcalfe H; Spicer D; Woodman P; Fox JC; Singh D
    Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma in malignant diseases.
    Wang T; Xu J; Yu X; Yang R; Han ZC
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):1-14. PubMed ID: 16388966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.